- Home
- IMUX vs PRPL Comparison
IMUX vs PRPL Comparison
Compare IMUX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- PRPL
- Stock Information
- Founded
- IMUX 2016
- PRPL 2010
- Country
- IMUX United States
- PRPL United States
- Employees
- IMUX N/A
- PRPL N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- PRPL Home Furnishings
- Sector
- IMUX Health Care
- PRPL Consumer Discretionary
- Exchange
- IMUX Nasdaq
- PRPL Nasdaq
- Market Cap
- IMUX 92.2M
- PRPL 96.6M
- IPO Year
- IMUX N/A
- PRPL N/A
- Fundamental
- Price
- IMUX $0.77
- PRPL $0.85
- Analyst Decision
- IMUX Strong Buy
- PRPL Hold
- Analyst Count
- IMUX 5
- PRPL 1
- Target Price
- IMUX $7.00
- PRPL $1.00
- AVG Volume (30 Days)
- IMUX 1.6M
- PRPL 393.7K
- Earning Date
- IMUX 11-06-2025
- PRPL 10-29-2025
- Dividend Yield
- IMUX N/A
- PRPL N/A
- EPS Growth
- IMUX N/A
- PRPL N/A
- EPS
- IMUX N/A
- PRPL N/A
- Revenue
- IMUX N/A
- PRPL $456,844,000.00
- Revenue This Year
- IMUX N/A
- PRPL N/A
- Revenue Next Year
- IMUX N/A
- PRPL $11.87
- P/E Ratio
- IMUX N/A
- PRPL N/A
- Revenue Growth
- IMUX N/A
- PRPL N/A
- 52 Week Low
- IMUX $0.56
- PRPL $0.56
- 52 Week High
- IMUX $1.48
- PRPL $1.29
- Technical
- Relative Strength Index (RSI)
- IMUX 37.43
- PRPL 43.45
- Support Level
- IMUX $0.78
- PRPL $0.78
- Resistance Level
- IMUX $0.86
- PRPL $0.91
- Average True Range (ATR)
- IMUX 0.05
- PRPL 0.05
- MACD
- IMUX -0.01
- PRPL -0.00
- Stochastic Oscillator
- IMUX 4.61
- PRPL 51.59
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.